MedTrace Logo

Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI

NCT03105882 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-03-19

No results posted yet for this study

Summary

Pilot Study of Clinical Safety and Feasibility of the Neuro-Spinal ScaffoldTM for the Treatment of Complete (AIS A) Traumatic Acute Spinal Cord Injury at the C5-T1 Neurological Levels The purpose of this study is to support an expansion to support marketing applications as well as future studies.

Conditions

  • Traumatic Cervical Acute Spinal Cord Injury

Interventions

DEVICE

Neuro-Spinal Scaffold

Experimental: Neuro-Spinal Scaffold

Sponsors & Collaborators

  • InVivo Therapeutics

    lead INDUSTRY

Principal Investigators

  • Richard Toselli, MD · InVivo Therapeutics

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2018-03-15
Completion
2018-03-15
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105882 on ClinicalTrials.gov